BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 18607981)

  • 1. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
    Lim YC; Lee JS; Choi EC
    Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Lohuis PJ; Klop WM; Tan IB; van Den Brekel MW; Hilgers FJ; Balm AJ
    Am J Surg; 2004 Feb; 187(2):295-9. PubMed ID: 14769324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity of level IV dissection in cN0 hypopharyngeal carcinoma.
    Shin YS; Kim SH; Koh YW; Hong HJ; Seol JH; Choi EC
    Acta Otolaryngol; 2011 Jun; 131(6):665-9. PubMed ID: 21395474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
    Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
    Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.
    Lim YC; Lee JS; Koo BS; Choi EC
    Laryngoscope; 2006 Feb; 116(2):268-72. PubMed ID: 16467717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it necessary to dissect levels I and IIB in hypopharyngeal cancer?
    Wiegand S; Esters J; Müller HH; Jäcker T; Roessler M; Werner JA; Sesterhenn AM
    Acta Otolaryngol; 2010 Jun; 130(6):747-52. PubMed ID: 19968609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
    Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
    Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic metastases to level IIb in hypopharyngeal squamous cell carcinoma.
    Kim YH; Koo BS; Lim YC; Lee JS; Kim SH; Choi EC
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1060-4. PubMed ID: 17043251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic selective neck dissection: a 25-year review.
    Muzaffar K
    Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lateral neck dissection of hypopharyngeal cancer with clinically regional metastasis].
    Wang X; Tang P; Tu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Jun; 35(3):175-7. PubMed ID: 12768770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
    Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planned neck dissection before combined chemoradiation for pyriform sinus carcinoma.
    Prades JM; Timoshenko AP; Schmitt TH; Delolme MP; Francoz M; Martin C; Saban-Roche L; Martin CH
    Acta Otolaryngol; 2008 Mar; 128(3):324-8. PubMed ID: 17851948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of selective neck dissection in the treatment of the clinically positive neck.
    Patel RS; Clark JR; Gao K; O'Brien CJ
    Head Neck; 2008 Sep; 30(9):1231-6. PubMed ID: 18642289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].
    Glanz H
    Laryngorhinootologie; 1999 Dec; 78(12):654-62. PubMed ID: 10666691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.